ChiCTR2500110542
尚未开始
/
/
/
2025-10-15
/
/
Cancer cervix
A Comparative study between Induction Chemotherapy Followed by Concurrent Chemoradiation versus Concurrent Chemoradiation in the Management of Locally Advanced Uterine Cervical Cancer
A Comparative study between Induction Chemotherapy Followed by Concurrent Chemoradiation versus Concurrent Chemoradiation in the Management of Locally Advanced Uterine Cervical Cancer
This study aims to explore the efficacy and tolerability of induction chemotherapy followed by chemoradiation versus conventional therapy chemoradiation in patients with locally advanced uterine cervical cancer.
随机平行对照
Ⅲ期
Randomization will be performed using a computer-generated random number table
Open-label
Sohag university
/
40
/
2025-10-12
2027-10-12
/
1.Age between 18 and 70 years; 2.Clinically staged as IB3–IVA according to the International Federation of Gynecology and Obstetrics (FIGO); 3.Histologically proved squamous cell carcinoma or adenocarcinoma of the uterine cervix; 4.Performance status 0–2 according to Word Health Organization (WHO) criteria; 5.Normal hematological, renal and hepatic function.；
请登录查看1.Severe systemic or uncontrolled disease (infection, central nervous system, metabolic, etc.) that precluded the use of chemotherapy; 2.Pre-existing high grade neuropathy of any cause; 3.Histologically proved small cell carcinoma, leiomyosarcoma, lymphoma and other histopathologies other than Squamous cell carcinoma & adenocarcinoma; 4.Mental illness; 5.Previous or concomitant malignancies.；
请登录查看Sohag university
/
英百瑞生物2025-12-05
艾力斯医药科技2025-12-05
神曦生物NeuExcell2025-12-05
科望医药2025-12-05
宠药生态圈2025-12-05
丁香园 Insight 数据库2025-12-05
佰傲谷BioValley2025-12-05
药精通Bio2025-12-05
医药观澜2025-12-05
贝达药业2025-12-05
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
